Urologists at University Hospital Basel are rising to the challenge of providing evidence-based prostate cancer treatment in an age of multidisciplinary care and accelerating medical progress. Thanks to artificial intelligence and smart data integration they can successfully deal with complexity and data overload.
We see big differences in care standards in different institutions.Professor Helge Seifert, MD, Head of Urology at USB, wants to give evidence-based treatment to every prostate cancer patient.
Evidence-based, patient-specific support at the urologist’s fingertips
AI Pathway Companion provides a comprehensive overview of every patient in every clinical situation.Christian Wetterauer, MD, senior urologist at the USB.
Use case: Multidisciplinary tumor board
“A tool like this will lead to better quality of care”
The urologist remains in the driving seat
“Seeing patient-specific decision trees unfold is very helpful”
The content in this material was created just prior to the outbreak of the C0VID-19 pandemic. Therefore, the depictions may not reflect the situation following the implementation of strict protective measures.
- The statements by Siemens Healthineers customers described herein are based on results that were achieved in the customer’s unique setting. Since there is no “typical” hospital and many variables exist (e.g., hospital size, case mix, level of IT adoption) there can be no guarantee that other customers will achieve the same results.